Digital coaching may help smokers with mental illness stay quit after hospital discharge

NCT ID NCT04367506

Completed Disease control Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study tests a digital smoking cessation program called BecomeAnEx, adapted for people with serious mental illness who want to quit or reduce smoking. Participants use a website, text messaging, and real-time coaching from a remote quit-smoking expert, plus an online community. The goal is to help them stay smoke-free after leaving the hospital, where they were temporarily abstinent.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a digital smoking cessation program called BecomeAnEx, which includes a website, text messaging, real-time coaching, and an online community
What this could lead to: If successful, this approach could help many people with serious mental illness stay smoke-free after leaving the hospital, reducing smoking-related health risks.
What could go wrong: This is a small pilot study with only 59 participants, so results may not apply to everyone. The program's success depends on internet access and personal motivation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TOBACCO CESSATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Tobacco Use Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TOBACCO CESSATION

Contacts and locations

Show contact details

Locations

Melanie Bennett

Baltimore, Maryland, 21021, United States
University of Maryland School of Medicine

Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.